Author: Dr. David Lowemann

FDA Halts Sale of Off-Brand Ozempic, Other GLP-1s

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on May 23, 2025

Staying Social Boosts Longevity

Seniors who stay socially engaged are much more likely to have longer lives, a new study says. Social engagement among seniors is associated with a lower risk of death, when compared to seniors who are loners, according to findings published May 21 in the Journal of the… Read Full Article (External Site) Dr. David LowemannDr. […]

Published on May 23, 2025

Study: E-Cigarettes Reinforce Nicotine Addiction

Pod-style e-cigarettes appear to be more addictive than nicotine gum, making it harder for vapers to kick the habit, a small-scale lab study has found. E-cigarettes reinforced nicotine addiction more than nicotine gum among young adults who regularly vape, results… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder […]

Published on May 23, 2025